Sanofi-aventis Ads (SNY) Earnings
|
Expand Research on SNY
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/28/22 | Q222 | N/A | EUR0.86 | N/A | N/A | EUR10.47B | N/A | N/A | N/A | ||
2/4/22  |
Q421 | N/A | $0.72 | N/A | N/A | $11.32B | N/A | N/A | N/A | ||
| 10/28/21 |
Q321 | N/A | $1.17 | N/A | N/A | $11.83B | N/A | N/A | N/A | ||
| 7/29/21 |
Q221 | N/A | $0.75 | N/A | N/A | $10.16B | N/A | N/A | N/A | ||
| 4/28/21 |
 |
Q121 | N/A | $0.78 | N/A | N/A | $10.43B | N/A | N/A | N/A | |
| 2/5/21 |
|
Q420 | N/A | $0.69 | N/A | N/A | $11.39B | N/A | N/A | N/A | |
| 10/29/20 |
Q320 | N/A | $1.09 | N/A | N/A | $11.61B | N/A | N/A | N/A | ||
| 7/29/20 |
|
Q220 | EUR1.28 | EUR1.21 | +EUR0.07 | EUR8.21B | EUR8.39B | N/A |  | | Details |
